What Mounjaro does to your metabolism — and why it matters

Tirzepatide activates both GIP and GLP-1 receptors, two gut hormones involved in appetite regulation, blood-sugar control and the way the body stores or burns energy.
Rather than raising metabolic rate directly, Mounjaro reduces appetite and slows gastric emptying, shifting the body into a sustained calorie deficit that encourages fat burning.
Clinical trial data published in the New England Journal of Medicine showed average weight reductions of around 20–21% at the highest dose over 72 weeks, reflecting meaningful metabolic change across thousands of participants.
Mounjaro is a Black Triangle (▼) medicine under additional MHRA monitoring; its metabolic effects should always be managed with prescriber oversight, including regular review of diet and activity.

Mounjaro (tirzepatide) changes how your body handles appetite, blood sugar and energy balance, but it does not speed up your resting metabolism in the way a stimulant would. The most significant metabolic shift is a sustained reduction in calorie intake driven by hormonal signalling, which then prompts the body to draw on stored fat for fuel. These are prescription-only medicines: a GPhC-registered prescriber reviews every consultation to assess whether tirzepatide is clinically appropriate for you, because the effects on metabolism vary and the full picture matters.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How tirzepatide reshapes metabolism — the decisions worth understanding

The hormone signals tirzepatide is actually changing

Most people searching for "Mounjaro and metabolism" are really asking whether the medicine changes how the body burns calories, or whether it simply helps you eat less. The honest answer is: both, but through a mechanism that is less like a furnace dial and more like a reset of the signals your gut sends to your brain.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) slows how quickly food moves through your stomach, prolonging the sensation of fullness after a meal. GIP (glucose-dependent insulinotropic polypeptide) works alongside it to improve how efficiently the body manages blood sugar and how readily fat tissue is mobilised for energy. No other licensed weight-loss medicine in the UK targets both pathways at once. You can read more about tirzepatide's pharmacology on the tirzepatide overview page.

The NHS medicines guidance on tirzepatide confirms that these combined receptor actions reduce appetite and food intake, improve insulin sensitivity and support a shift toward using stored fat as fuel. The result is not a dramatic increase in basal metabolic rate on a calorie-in/calorie-out calculation, but a genuine and sustained change in how the body is using and prioritising energy sources.

If you want to understand exactly what those hormonal changes mean in practice, our page on how Mounjaro helps metabolism explains how the dual-pathway mechanism translates into real-world energy use. Understanding what tirzepatide does to metabolism at this level matters for setting realistic expectations: the medicine changes the hormonal environment that governs eating behaviour, not the raw number of calories your cells burn at rest.

Why a calorie deficit alone does not explain the metabolic story

A common worry is that reducing food intake sharply will trigger the body's adaptive response, the well-documented slowdown in resting metabolism that follows prolonged calorie restriction. This concern is reasonable. Severe dieting alone can reduce metabolic rate as the body preserves energy stores.

What the SURMOUNT-1 trial data suggest is that the hormonal environment created by tirzepatide appears to mitigate some of that adaptation. Participants on tirzepatide maintained higher rates of fat mass reduction relative to lean mass loss compared with placebo, which is relevant because muscle tissue is metabolically more active than fat. Preserving lean mass means the metabolic cost of running the body stays higher. Whether tirzepatide meaningfully protects resting metabolic rate beyond what calorie restriction alone would cause is still an active area of research, our page on whether Mounjaro slows metabolism covers the evidence more closely.

Protein intake and resistance exercise are widely recommended alongside GLP-1 treatment for this reason: they support muscle retention during the weight-loss phase. A prescriber can talk through what that looks like in practice for you, because the right balance depends on your starting point and how your body is responding to treatment.

What this means when you are deciding whether to start treatment

If you are weighing up Mounjaro as a treatment option, the metabolic effects are worth understanding clearly rather than as a vague promise of "boosted metabolism." The medicine does not override your biology; it works with it, using the body's own hormonal feedback loops.

The licensed eligibility criteria for private treatment are an adult BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, raised cholesterol or type 2 diabetes. A prescriber assesses the full clinical picture, current health, medications and medical history all interact with how tirzepatide affects metabolism and what effects are appropriate to expect.

Pricing and service details sit outside this page's scope, but if cost is part of your decision you can review how Mounjaro is prescribed privately in the UK for a clear breakdown. Our clinical team profile is at the prescribers page if you want to understand who reviews consultations at nume.

One practical note on routine: Mounjaro is stored in the fridge between 2°C and 8°C, many people find keeping it on the fridge door, alongside things they check daily, makes the once-weekly injection easier to remember. The Patient Information Leaflet gives the exact storage and handling guidance; a prescriber will walk you through it at the start of treatment.

The metabolic question does not have a one-sentence answer. But the core of it is this: tirzepatide changes the hormonal signals that govern hunger and fuel use, creating the conditions for fat loss while preserving lean tissue better than calorie restriction alone tends to. For a fuller look at specific aspects, the how Mounjaro affects metabolism page and the does Mounjaro boost metabolism page go deeper on different angles. You can also explore the wider range of weight-loss treatment options to compare where tirzepatide fits for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions